SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease - Nature Medicine

We thank the patients who took part in the trial; the 35 investigators from 11 recruiting centers and their research staff members; colleagues at UK Health Security Agency , including Bassam Hallis, Cathy Rowe and Sue Charlton; and the staff from the Cancer Research UK Clinical Trials Unit , University of Birmingham, including P. Boateng, H. Doyle and J. Mason.

Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, London, UKCancer Research UK Clinical Trials Unit , University of Birmingham, Edgbaston, Birmingham, UK Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, Sheffield, UKDepartment of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, UKWellcome Centre for Human Genetics, University of Oxford, Oxford, UK

Sarah Foulkes, Victoria Hall, Susan Hopkins, Jasmin Islam, Ashley Otter, Kevin Brown & Gayatri AmirthalingamSarah L.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Using gut microorganisms to treat cancer - Nature MedicineStrategies to monitor and modulate gut microorganisms to improve immunity and responses to cancer immunotherapy are increasingly available, with opportunities to expand and iterate on these approaches to treat, intercept and prevent cancer (and other diseases) altogether.
Source: NatureMedicine - 🏆 451. / 53 Read more »